Skip to main content
38°
Partly Cloudy
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
News
Local News
State News
Sports
Local Sports
Pro Sports
Lifestyle
Local Entertainment
Multimedia
Community Choice
Features
Special Sections
Local Events
Weather
Classifieds
Place Ad
Legal Notices
Place Call Legal
Search Call Legals
Place Times Legal
Search Times Legals
Public Notices
Obituaries
E-Edition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
McKesson Corp
(NY:
MCK
)
693.53
+19.84 (+2.94%)
Official Closing Price
Updated: 7:00 PM EDT, Apr 2, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about McKesson Corp
< Previous
1
2
3
4
5
6
7
8
9
...
19
20
Next >
3 Attractive Medical Stocks To Buy After Earnings
February 08, 2024
Quite a few top-rated stocks have highlighted this week’s earnings lineup with now appearing to be an ideal time to buy. Following their favorable quarterly results, here are 3 intriguing healthcare...
Via
Talk Markets
Medical Supplies-Focused McKesson Shares Fall On Q3 Earnings Performance, Analyst Says Street 'Wanted More'
February 08, 2024
McKesson beats expectations with Q3 2024 sales of $80.9 billion, up 15%. U.S. Pharmaceutical Segment thrives, adjusted EPS at $7.74, exceeding consensus.
Via
Benzinga
If You Invested $1000 In This Stock 5 Years Ago, You Would Have $3,900 Today
February 08, 2024
Via
Benzinga
McKesson (MCK) Q3 2024 Earnings Call Transcript
February 07, 2024
MCK earnings call for the period ending December 31, 2023.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
McKesson Corporation Reports Fiscal 2024 Third Quarter Results and Raises Full Year Guidance
February 07, 2024
From
McKesson Corporation
Via
Business Wire
Earnings Scheduled For February 7, 2024
February 07, 2024
Companies Reporting Before The Bell • Madison Square Garden (NYSE:MSGE) is expected to report quarterly loss at $0.80 per share on revenue of $301.83 million.
Via
Benzinga
Earnings Preview: McKesson
February 06, 2024
Via
Benzinga
Here's How Much $1000 Invested In McKesson 5 Years Ago Would Be Worth Today
January 19, 2024
Via
Benzinga
Peering Into McKesson's Recent Short Interest
January 15, 2024
Via
Benzinga
S&P 500 Flirts With 5,000 As Magnificent 7 Tops $13 Trillion, NYCB Sinks: What's Driving Markets Wednesday?
February 07, 2024
Wednesday is a bullish day on Wall Street, with major large-cap indices extending record highs, aided by robust corporate earnings. Despite the overall market optimism, concerns linger within segments...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
McKesson Earnings Are Imminent; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
February 07, 2024
McKesson Corporation (NYSE: MCK) is expected to release earnings results for its third quarter, after the closing bell on Feb. 7, 2024.
Via
Benzinga
Fear & Greed Index Remains In 'Greed' Zone Following Earnings Reports; Dow Jumps Over 100 Points
February 07, 2024
The CNN Money Fear and Greed index showed a slight improvement in the overall market sentiment, while the index remained in the "Greed" zone on Tuesday. U.S. stocks closed higher on Tuesday, as...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
If You Invested $1000 In This Stock 15 Years Ago, You Would Have $12,000 Today
January 05, 2024
Via
Benzinga
Check Out What Whales Are Doing With MCK
January 03, 2024
Via
Benzinga
How Is The Market Feeling About McKesson?
December 25, 2023
Via
Benzinga
Wall Street's Top 10 Stock Calls This Week - Saturday, Feb. 3
February 03, 2024
What has Wall Street been buzzing about this week? Here are the top 5 buy calls and the top 5 sell calls made by Wall Street's best analysts during the week of Jan. 29 through Feb. 2.
Via
Talk Markets
McKesson Corporation Declares Quarterly Dividend
February 01, 2024
From
McKesson Corporation
Via
Business Wire
McKesson Corp. (NYSE: MCK) Highlighted for Surprising Price Action
January 31, 2024
Via
Investor Brand Network
Topics
Economy
Exposures
Supply Chain
3 Hidden Healthcare Stocks Poised for a Breakout This Year
January 30, 2024
As the market preferences start to switch toward stable and defensive names like healthcare, these stocks could help your portfolio.
Via
InvestorPlace
McKesson Corp. (NYSE: MCK) Records 52-Week High Wednesday Morning
January 17, 2024
Via
Investor Brand Network
Topics
Economy
Exposures
Supply Chain
Here's How Much You Would Have Made Owning McKesson Stock In The Last 5 Years
December 18, 2023
Via
Benzinga
What 5 Analyst Ratings Have To Say About McKesson
December 11, 2023
Via
Benzinga
How Is The Market Feeling About McKesson?
December 08, 2023
Via
Benzinga
McKesson to Present at the 42nd Annual J.P. Morgan Healthcare Conference
January 09, 2024
From
McKesson Corporation
Via
Business Wire
Exceeding Expectations: McKesson Achieves Strong Performance and Rewards Investors
January 02, 2024
On January 02, 2024, McKesson (NYSE:MCK) will distribute a dividend payout of $0.62 per share, equating to an annualized dividend yield of 0.55%. Shareholders who owned the stock before the ex-dividend...
Via
Benzinga
McKesson Corporation Announces Third Quarter Fiscal 2024 Earnings Release Date and Participation in January Conference
December 27, 2023
From
McKesson Corporation
Via
Business Wire
Silver Economy Successes: 3 Stocks Benefitting From an Aging Population
December 27, 2023
Explore our in-depth analysis of aging population stocks, uncovering the opportunities and challenges in this sector.
Via
InvestorPlace
Topics
Economy
Exposures
Economy
Here's How Much $100 Invested In McKesson 15 Years Ago Would Be Worth Today
December 01, 2023
Via
Benzinga
Calliditas Therapeutics Scores Complete FDA Approval, Broader Label For Lead Kidney Disease Drug
December 21, 2023
The FDA approved Calliditas Therapeutics AB's (NASDAQ: CALT) Tarpeyo (budesonide) delayed-release capsules to reduce the loss of kidney function in adults with primary immunoglobulin A nephropathy...
Via
Benzinga
Exposures
Product Safety
This 1 Surprising New Tailwind Is Lifting These 2 Evergreen Stocks
December 04, 2023
New growth drivers are helping to propel these reliable and steady businesses.
Via
The Motley Fool
< Previous
1
2
3
4
5
6
7
8
9
...
19
20
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.